about
Prevention and Control of Antimicrobial Resistant Healthcare-Associated Infections: The Microbiology Laboratory Rocks!MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosisIdentification of Highly Pathogenic Microorganisms by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry: Results of an Interlaboratory Ring TrialMassively parallel digital high resolution melt for rapid and absolutely quantitative sequence profilingEvaluation of the Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System for Identification of Clinically Relevant Filamentous FungiHead-to-head comparison of Microflex LT and Vitek MS systems for routine identification of microorganisms by MALDI-TOF mass spectrometry in Chile.Assessment of Reproducibility of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Bacterial and Yeast IdentificationSevere Community-Acquired Pneumonia with Bacteremia Caused by Herbaspirillum aquaticum or Herbaspirillum huttiense in an Immune-Competent AdultPeaks of Promise and Peril: Screening for Antibiotic Resistance by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryA Simple and Safe Protocol for Preparing Brucella Samples for Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Analysis.A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory.Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations.MALDI-TOF Mass Spectrometry: A Powerful Tool for Clinical Microbiology at Hôpital Principal de Dakar, Senegal (West Africa).MALDI-TOF MS in clinical parasitology: applications, constraints and prospects.New Developments in Clinical Bacteriology Laboratories.Implementation of rapid diagnostics with antimicrobial stewardship.Clinical Significance of Commensal Gram-Positive Rods Routinely Isolated from Patient SamplesExploring MALDI-TOF MS approach for a rapid identification of Mycobacterium avium ssp. paratuberculosis field isolates.Comparing genome versus proteome-based identification of clinical bacterial isolates.Characterization of Multidrug Resistant E. faecalis Strains from Pigs of Local Origin by ADSRRS-Fingerprinting and MALDI -TOF MS; Evaluation of the Compatibility of Methods Employed for Multidrug Resistance Analysis.[Advances in diagnostic microbiology : Opportunities and limitations].Discrimination of Streptococcus equi subsp. equi and Streptococcus equi subsp. zooepidemicus using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Impact of updating the MALDI-TOF MS database on the identification of nontuberculous mycobacteria.Rapid bacterial antibiotic susceptibility test based on simple surface-enhanced Raman spectroscopic biomarkersOn-Chip spectroscopic assessment of microbial susceptibility to antibiotics within 3.5 hours.Diagnostics and susceptibility testing in Aspergillus.Use of MALDI-TOF mass spectrometry in the battle against bacterial infectious diseases: recent achievements and future perspectives.Mining the fecal proteome: from biomarkers to personalised medicine.Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship ProgramsAntimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.Direct detection of extended-spectrum beta-lactamases (CTX-M) from blood cultures by LC-MS/MS bottom-up proteomics.Meningitis and Bacteremia Due to Neisseria cinerea following a Percutaneous Rhizotomy of the Trigeminal Ganglion.A Novel Peptidomic Approach to Strain Typing of Clinical Acinetobacter baumannii Isolates Using Mass Spectrometry.Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.Prediction of microbe-disease association from the integration of neighbor and graph with collaborative recommendation model.Identification of clinical isolates of Aspergillus, including cryptic species, by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).Total Laboratory Automation and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Improve Turnaround Times in the Clinical Microbiology Laboratory: a Retrospective Analysis.Validation of a novel automatic deposition of bacteria and yeasts on MALDI target for MALDI-TOF MS-based identification using MALDI Colonyst robot.Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.NaOH-HCl neutralized urine preparation for direct testing of uropathogens by Bruker MS.
P2860
Q26745072-F42F3E82-CA73-4506-B8DF-E8BF8AED44B6Q26795481-22017904-FE42-42F9-9E28-7232610BFCFDQ28646772-8B7E16B2-6FFC-4D20-BF66-4EE37BE0EC07Q28817256-10056C29-C297-43D2-A8AA-2D4213681097Q28828658-058B96EB-7BAD-4923-8FB0-018DDB3FE6CDQ33704296-8BAFC4C8-E5D0-4BB9-AC9F-EFB5393D6369Q35618485-E93E1AF8-226C-48F6-967C-DBE16656E072Q35693041-4F8A3A0F-3810-46DE-915D-9429D225FAA0Q35839163-69FF3F9F-DDEC-4B83-8491-F18FF8097A44Q35845958-B04455AF-7BCA-4F59-B1F2-C181953B2BFFQ35867084-91EBEA89-A04C-47E0-9F0C-F1028EED05AFQ35880037-F9E7DFD9-A2C7-41EE-A926-D0AF854C4A97Q35881548-6314AB4B-E078-4373-B299-82E0A90017ABQ36069646-61E22BB8-81E0-46D7-BDBC-8167EF3E1758Q36110566-AEE0936D-403A-41E9-93D1-DCE863EDFF3EQ36124261-26BC814A-96EC-42A1-87F9-34AD4BFF5F12Q36133418-9531D51D-F0C0-486C-9D32-CFCEBA8DB33DQ36199144-57561CE3-0B7D-4914-B508-9006568EFFF9Q36232883-DBA3DE69-C80B-42C9-A81C-103444B706CBQ36263953-34F736EC-0C18-4238-8A68-0869629026A2Q36322946-0FE02FFB-E334-4C75-B334-F7ABADD79D85Q36359952-71319880-C8EF-47C3-A261-A5E95D46A1A2Q36365452-E4D5A0BC-2259-4796-A218-BAD86BC91E3EQ36707786-5C5C3DA3-2237-4255-9229-7F5240B5133CQ38688446-BA097EE9-51E6-43E2-AEAE-86D8C2C99153Q38723910-41B50C7B-E71D-4D6A-B7EE-C6D13B7AB7D9Q38769874-6E3DD3D3-D091-485D-9E9B-E8C7D6336FD3Q38865393-40D78C4A-63E0-4253-B492-31F40B863963Q39274504-C7AA89F1-4636-4847-ADE8-6AD1B7B0CC89Q39451464-E960A801-7170-4776-9EB2-9F7DB844CD5DQ40256805-88456942-32AB-4EFE-9186-96ACAA21C056Q40381995-F39105E1-6E3A-4D03-8A2D-48BF156C9738Q40697998-00C58C5C-A174-4591-8E5A-249D2CF9F56DQ42104058-7A86C01B-795B-42B5-9EEA-55B579061794Q42656052-508C23DD-7968-46ED-A3B7-38DB0733EE5CQ46243717-8BB790BF-1E04-49C3-A5BE-53D525C12D74Q47140359-28052257-9BBB-400C-AD4D-117A41380D38Q47234065-635F623D-4700-4F7D-9799-DE12C6AC498EQ47554066-B5D10921-AA9A-4D80-A352-756D21086A7CQ47992911-0A75D0BF-E9EF-48CF-957F-E1BDB8908F41
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MALDI-TOF MS for the diagnosis of infectious diseases.
@ast
MALDI-TOF MS for the diagnosis of infectious diseases.
@en
type
label
MALDI-TOF MS for the diagnosis of infectious diseases.
@ast
MALDI-TOF MS for the diagnosis of infectious diseases.
@en
prefLabel
MALDI-TOF MS for the diagnosis of infectious diseases.
@ast
MALDI-TOF MS for the diagnosis of infectious diseases.
@en
P1433
P1476
MALDI-TOF MS for the diagnosis of infectious diseases.
@en
P2093
Robin Patel
P304
P356
10.1373/CLINCHEM.2014.221770
P407
P577
2014-10-02T00:00:00Z